Literature DB >> 17613695

Akt in ischemia and reperfusion.

Carolyn J Mullonkal1, Luis H Toledo-Pereyra.   

Abstract

Injury due to ischemia and reperfusion (I/R) causes an inflammatory response due to oxidative damage, which triggers stress signaling processes that eventually result in cell apoptosis and death. There are a number of chemical mediators and pathways involved in the I/R response. Thus from a therapeutic point of view, it would be most efficient to focus on the most important active mediators of inflammation and apoptosis and manipulate these to improve cell function and survival. Over the last few years, the Akt pathway has become such a target due to its role as a signaling pathway where modulation of substrates prevents apoptosis. The involvement of Akt in the cell survival pathway is a complex process that requires an extensive machinery of intracellular events. The aim of this review is to organize these findings to better understand Akt's mechanism of protection and how it modulates specific substrates in the heart, liver, and brain affected by I/R. Akt functions as a survival kinase by phosphorylating a number of apoptosis-regulatory molecules such as BAD, forkhead transcription factors, caspase 9, and IkappaB kinase to influence NF-kappaB and GSK-3beta. Akt's broad scope places it at the center of multiple critical steps, allowing it to play a protective role in various organs affected by I/R injury. From a practical and clinical application point of view, the upregulation of Akt could potentially be used alone or in combination with other therapeutic strategies to treat I/R injury and thus to improve cell and organ function. The means by which Akt manipulation should occur is not well defined, and it is possible that pharmacologically, such as in the case of selectin inhibitors in our experience or through well-orchestrated gene therapy, this important molecule can be better upregulated and therefore can offer effective protection. The short- and long-term effects with Akt upregulation have not been well studied so far. Early concerns about cancer or cardiac damage potential are inconclusive. Thus, more experiments are required in this particular area of research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613695     DOI: 10.1080/08941930701366471

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  65 in total

1.  TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury.

Authors:  Sergio Duarte; Takashi Hamada; Naohisa Kuriyama; Ronald W Busuttil; Ana J Coito
Journal:  Hepatology       Date:  2012-07-11       Impact factor: 17.425

Review 2.  Mesh biocompatibility: effects of cellular inflammation and tissue remodelling.

Authors:  Karsten Junge; Marcel Binnebösel; Klaus T von Trotha; Raphael Rosch; Uwe Klinge; Ulf P Neumann; Petra Lynen Jansen
Journal:  Langenbecks Arch Surg       Date:  2011-04-01       Impact factor: 3.445

3.  Embryonic stem cells improve cardiac function in Doxorubicin-induced cardiomyopathy mediated through multiple mechanisms.

Authors:  Dinender K Singla; Aisha Ahmed; Reetu Singla; Binbin Yan
Journal:  Cell Transplant       Date:  2012-03-22       Impact factor: 4.064

4.  Insulin ameliorates miR-1-induced injury in H9c2 cells under oxidative stress via Akt activation.

Authors:  Tao Chen; Guoliang Ding; Zhuqing Jin; Mary B Wagner; Zuyi Yuan
Journal:  Mol Cell Biochem       Date:  2012-07-18       Impact factor: 3.396

5.  DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion.

Authors:  Hui-Chun Ku; Wen-Pin Chen; Ming-Jai Su
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-07-12       Impact factor: 3.000

6.  Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.

Authors:  Emma Sierecki; William Sinko; J Andrew McCammon; Alexandra C Newton
Journal:  J Med Chem       Date:  2010-10-14       Impact factor: 7.446

7.  Transglutaminase-1 protects renal epithelial cells from hydrogen peroxide-induced apoptosis through activation of STAT3 and AKT signaling pathways.

Authors:  Murugavel Ponnusamy; Maoyin Pang; Pavan Kumar Annamaraju; Zhu Zhang; Rujun Gong; Y Eugene Chin; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2009-08-26

8.  Regulation of a truncated isoform of AMP-activated protein kinase α (AMPKα) in response to hypoxia in the muscle of Pacific oyster Crassostrea gigas.

Authors:  Eric Guévélou; Arnaud Huvet; Rossana Sussarellu; Massimo Milan; Ximing Guo; Li Li; Guofan Zhang; Virgile Quillien; Jean-Yves Daniel; Claudie Quéré; Pierre Boudry; Charlotte Corporeau
Journal:  J Comp Physiol B       Date:  2013-01-25       Impact factor: 2.200

9.  The role of Akt/protein kinase B subtypes in retinal ischemic preconditioning.

Authors:  John C Dreixler; Jonathan W Hemmert; Shanti K Shenoy; Yang Shen; H Thomas Lee; Afzhal R Shaikh; Daniel M Rosenbaum; Steven Roth
Journal:  Exp Eye Res       Date:  2008-12-03       Impact factor: 3.467

10.  Toll-like receptor-3 activation increases the vulnerability of the neonatal brain to hypoxia-ischemia.

Authors:  Linnea Stridh; Amin Mottahedin; Maria E Johansson; Raul Chavez Valdez; Frances Northington; Xiaoyang Wang; Carina Mallard
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.